Publication Name	World Journal of Clinical Pediatrics
Manuscript ID	19763
Country	Australia

Received	2015-05-20 09:59
Peer-Review Started	2015-05-20 23:55
To Make the First Decision	2015-07-27 15:46
Return for Revision	2015-08-04 09:37
Revised	2015-08-07 13:42
Second Decision	2015-09-14 10:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-28 17:48
Articles in Press	2015-09-28 17:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-20 18:50
Publish the Manuscript Online	2015-11-10 12:29

ISSN	2219-2808 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pediatrics
Manuscript Type	Review
Article Title	Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions
Manuscript Source	Invited Manuscript
All Author List	Genevieve Ho, Michael Cardamone and Michelle Farrar
Funding Agency and Grant Number
Corresponding Author	Dr. Michelle Farrar, MBBS, FRACP, PhD, Department of Neurology, Sydney Children’s Hospital, High St, Randwick NSW 2031, Australia. m.farrar@unsw.edu.au
Key Words	Clinical manifestations; Myotonic dystrophy type 1; Childhood myotonic dystrophy; Congenital myotonic dystrophy; Natural history; Management
Core Tip	Type 1 myotonic dystrophy is an often undetected neuromuscular disease in paediatric patients with variable clinical manifestations and burden of disease. We review the current understandings of disease pathogenesis, symptoms and management in congenital and childhood myotonic dystrophy with a particular focus on hypersomnolence and sleep disorders. Future directions should target standardised care and regular surveillance, understanding pathophysiology and new treatment strategies.
Publish Date	2015-11-10 12:29
Citation	Ho G, Cardamone M, Farrar M. Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions. World J Clin Pediatr 2015; 4(4): 66-80
URL	http://www.wjgnet.com/2219-2808/full/v4/i4/66.htm
DOI	http://dx.doi.org/10.5409/wjcp.v4.i4.66

Full Article (PDF)	WJCP-4-66.pdf
Full Article (Word)	WJCP-4-66.doc
Manuscript File	19763-Review.docx
Answering Reviewers	19763-Answering reviewers.pdf
Audio Core Tip	19763-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19763-Conflict-of-interest statement.pdf
Copyright License Agreement	19763-Copyright assignment.pdf
Peer-review Report	19763-Peer-review(s).pdf
Scientific Misconduct Check	19763-Scientific misconduct check.pdf
Scientific Editor Work List	19763-Scientific editor work list.pdf